The KP.2-adapted COVID-19 vaccine improves neutralising activity against the XEC variant

The limitations of this study include the small cohort size, age group, examination of a single timepoint, and unknown effect of previous SARS-CoV-2 exposure or the cellular immune responses. The funders played no role in the design and conduct of the study; collection, management, analysis, and int...

Full description

Saved in:
Bibliographic Details
Published inThe Lancet infectious diseases Vol. 25; no. 3; pp. e122 - e123
Main Authors Suthar, Mehul S, Manning, Kelly E, Ellis, Madison L, Jain, Shilpi, Bechnak, Kareem, Vander Velden, Jake, Laboune, Farida, Henry, Amy R, Godbole, Sucheta, Kim, Sungjin, Sahoo, Malaya K, Paredes, Isabel, Dib, Serena M, Kalash, Suha, Radi, Christelle, Hicks, Heather, Tamin, Azaibi, Gardner, Meredith, Bowen, Nicole, Cook, Peter, Paden, Clinton, Harcourt, Jennifer, Pinsky, Benjamin A, Douek, Daniel C, Rouphael, Nadine, Moreno, Alberto
Format Journal Article
LanguageEnglish
Published United States Elsevier Ltd 01.03.2025
Elsevier Limited
Subjects
Online AccessGet full text

Cover

Loading…
Abstract The limitations of this study include the small cohort size, age group, examination of a single timepoint, and unknown effect of previous SARS-CoV-2 exposure or the cellular immune responses. The funders played no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication. MSS served in an advisory role and received funds to conduct research from Ocugen.
AbstractList The limitations of this study include the small cohort size, age group, examination of a single timepoint, and unknown effect of previous SARS-CoV-2 exposure or the cellular immune responses. The funders played no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication. MSS served in an advisory role and received funds to conduct research from Ocugen.
Author Harcourt, Jennifer
Douek, Daniel C
Godbole, Sucheta
Paden, Clinton
Moreno, Alberto
Vander Velden, Jake
Rouphael, Nadine
Bechnak, Kareem
Bowen, Nicole
Dib, Serena M
Cook, Peter
Jain, Shilpi
Kim, Sungjin
Radi, Christelle
Tamin, Azaibi
Ellis, Madison L
Kalash, Suha
Suthar, Mehul S
Manning, Kelly E
Laboune, Farida
Henry, Amy R
Pinsky, Benjamin A
Paredes, Isabel
Hicks, Heather
Sahoo, Malaya K
Gardner, Meredith
Author_xml – sequence: 1
  givenname: Mehul S
  surname: Suthar
  fullname: Suthar, Mehul S
  email: msuthar@emory.edu
  organization: Center for Childhood Infections and Vaccines, Children's Healthcare of Atlanta, Division of Infectious Diseases, Department of Pediatrics, Emory University School of Medicine, Atlanta, GA 30329, USA
– sequence: 2
  givenname: Kelly E
  surname: Manning
  fullname: Manning, Kelly E
  organization: Center for Childhood Infections and Vaccines, Children's Healthcare of Atlanta, Division of Infectious Diseases, Department of Pediatrics, Emory University School of Medicine, Atlanta, GA 30329, USA
– sequence: 3
  givenname: Madison L
  surname: Ellis
  fullname: Ellis, Madison L
  organization: Center for Childhood Infections and Vaccines, Children's Healthcare of Atlanta, Division of Infectious Diseases, Department of Pediatrics, Emory University School of Medicine, Atlanta, GA 30329, USA
– sequence: 4
  givenname: Shilpi
  surname: Jain
  fullname: Jain, Shilpi
  organization: Center for Childhood Infections and Vaccines, Children's Healthcare of Atlanta, Division of Infectious Diseases, Department of Pediatrics, Emory University School of Medicine, Atlanta, GA 30329, USA
– sequence: 5
  givenname: Kareem
  surname: Bechnak
  fullname: Bechnak, Kareem
  organization: Hope Clinic of Emory Vaccine Center, Emory University, Decatur, GA, USA
– sequence: 6
  givenname: Jake
  surname: Vander Velden
  fullname: Vander Velden, Jake
  organization: Center for Childhood Infections and Vaccines, Children's Healthcare of Atlanta, Division of Infectious Diseases, Department of Pediatrics, Emory University School of Medicine, Atlanta, GA 30329, USA
– sequence: 7
  givenname: Farida
  surname: Laboune
  fullname: Laboune, Farida
  organization: Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA
– sequence: 8
  givenname: Amy R
  surname: Henry
  fullname: Henry, Amy R
  organization: Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA
– sequence: 9
  givenname: Sucheta
  surname: Godbole
  fullname: Godbole, Sucheta
  organization: Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA
– sequence: 10
  givenname: Sungjin
  surname: Kim
  fullname: Kim, Sungjin
  organization: Center for Childhood Infections and Vaccines, Children's Healthcare of Atlanta, Division of Infectious Diseases, Department of Pediatrics, Emory University School of Medicine, Atlanta, GA 30329, USA
– sequence: 11
  givenname: Malaya K
  surname: Sahoo
  fullname: Sahoo, Malaya K
  organization: Stanford University School of Medicine, Stanford, CA, USA
– sequence: 12
  givenname: Isabel
  surname: Paredes
  fullname: Paredes, Isabel
  organization: Hope Clinic of Emory Vaccine Center, Emory University, Decatur, GA, USA
– sequence: 13
  givenname: Serena M
  surname: Dib
  fullname: Dib, Serena M
  organization: Hope Clinic of Emory Vaccine Center, Emory University, Decatur, GA, USA
– sequence: 14
  givenname: Suha
  surname: Kalash
  fullname: Kalash, Suha
  organization: Hope Clinic of Emory Vaccine Center, Emory University, Decatur, GA, USA
– sequence: 15
  givenname: Christelle
  surname: Radi
  fullname: Radi, Christelle
  organization: Hope Clinic of Emory Vaccine Center, Emory University, Decatur, GA, USA
– sequence: 16
  givenname: Heather
  surname: Hicks
  fullname: Hicks, Heather
  organization: Centers for Disease Control and Prevention, National Center for Immunization and Respiratory Diseases, Atlanta, GA, USA
– sequence: 17
  givenname: Azaibi
  surname: Tamin
  fullname: Tamin, Azaibi
  organization: Centers for Disease Control and Prevention, National Center for Immunization and Respiratory Diseases, Atlanta, GA, USA
– sequence: 18
  givenname: Meredith
  surname: Gardner
  fullname: Gardner, Meredith
  organization: Centers for Disease Control and Prevention, National Center for Immunization and Respiratory Diseases, Atlanta, GA, USA
– sequence: 19
  givenname: Nicole
  surname: Bowen
  fullname: Bowen, Nicole
  organization: Centers for Disease Control and Prevention, National Center for Immunization and Respiratory Diseases, Atlanta, GA, USA
– sequence: 20
  givenname: Peter
  surname: Cook
  fullname: Cook, Peter
  organization: Centers for Disease Control and Prevention, National Center for Immunization and Respiratory Diseases, Atlanta, GA, USA
– sequence: 21
  givenname: Clinton
  surname: Paden
  fullname: Paden, Clinton
  organization: Centers for Disease Control and Prevention, National Center for Immunization and Respiratory Diseases, Atlanta, GA, USA
– sequence: 22
  givenname: Jennifer
  surname: Harcourt
  fullname: Harcourt, Jennifer
  organization: Centers for Disease Control and Prevention, National Center for Immunization and Respiratory Diseases, Atlanta, GA, USA
– sequence: 23
  givenname: Benjamin A
  surname: Pinsky
  fullname: Pinsky, Benjamin A
  organization: Stanford University School of Medicine, Stanford, CA, USA
– sequence: 24
  givenname: Daniel C
  surname: Douek
  fullname: Douek, Daniel C
  organization: Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA
– sequence: 25
  givenname: Nadine
  surname: Rouphael
  fullname: Rouphael, Nadine
  organization: Hope Clinic of Emory Vaccine Center, Emory University, Decatur, GA, USA
– sequence: 26
  givenname: Alberto
  surname: Moreno
  fullname: Moreno, Alberto
  email: camoren@emory.edu
  organization: Emory Vaccine Center, Emory University, Atlanta, GA, USA
BackLink https://www.ncbi.nlm.nih.gov/pubmed/39900094$$D View this record in MEDLINE/PubMed
BookMark eNqNkUtLAzEUhYMovn-CMuBGF6N5TpqFiNQnCgo-cBfSzK1Gp5maZAr998ZWXbjRbBLCd869nLOGFn3rAaEtgvcJJtXBHeGSlQwrtUvFHs5HltUCWs3fvORcyMXZe46soLUYXzEmkmC-jFaYUlmg-Cp6un-B4up2n5amNuMEddG_ebw8KYkqJsZa56Fwo3FoJxALD10KpnHR-efC2OQmLk0L82ycj6lI2ejptJ9lwRmfNtDS0DQRNr_udfRwdnrfvyivb84v-8fXpWVKpJLnIQKAwoCxykjGCSc1ZpwPpOBGCMqGUilqFVWWCMCs16M9ZpkQwK3hhK2j3blvXvK9g5j0yEULTWM8tF3UjFSMUtrjNKM7v9DXtgs-b5cpSSqJKVaZ2v6iusEIaj0ObmTCVH9nlgExB2xoYwww_EEI1p_d6Fk3-jN4TYWedaOrrDua6yDHMXEQdLQOvIXaBbBJ16370-Hwl4NtnHfWNG8w_Yf-A1_IpLc
Cites_doi 10.1016/S1473-3099(24)00738-2
10.1016/j.celrep.2024.114520
10.15585/mmwr.mm7337e2
ContentType Journal Article
Copyright 2025 Elsevier Ltd
2025. Elsevier Ltd
Copyright_xml – notice: 2025 Elsevier Ltd
– notice: 2025. Elsevier Ltd
DBID AAYXX
CITATION
NPM
0TZ
3V.
7QL
7RV
7U9
7X7
7XB
88E
8AO
8C1
8C2
8FI
8FJ
8FK
ABUWG
AEUYN
AFKRA
BENPR
C1K
CCPQU
FYUFA
GHDGH
H94
K9.
KB0
M0S
M1P
M7N
NAPCQ
PHGZM
PHGZT
PJZUB
PKEHL
PPXIY
PQEST
PQQKQ
PQUKI
PRINS
7X8
DOI 10.1016/S1473-3099(25)00007-6
DatabaseName CrossRef
PubMed
Pharma and Biotech Premium PRO
ProQuest Central (Corporate)
Bacteriology Abstracts (Microbiology B)
Nursing & Allied Health Database
Virology and AIDS Abstracts
Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Medical Database (Alumni Edition)
ProQuest Pharma Collection
Public Health Database (ProQuest)
Lancet Titles
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni)
ProQuest One Sustainability
ProQuest Central UK/Ireland
ProQuest Central
Environmental Sciences and Pollution Management
ProQuest One
Health Research Premium Collection
Health Research Premium Collection (Alumni)
AIDS and Cancer Research Abstracts
ProQuest Health & Medical Complete (Alumni)
Nursing & Allied Health Database (Alumni Edition)
ProQuest Health & Medical Collection
Medical Database
Algology Mycology and Protozoology Abstracts (Microbiology C)
Nursing & Allied Health Premium
ProQuest Central Premium
ProQuest One Academic (New)
ProQuest Health & Medical Research Collection
ProQuest One Academic Middle East (New)
ProQuest One Health & Nursing
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
MEDLINE - Academic
DatabaseTitle CrossRef
PubMed
Pharma and Biotech Premium PRO
ProQuest One Academic Middle East (New)
Lancet Titles
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
ProQuest One Community College
ProQuest One Health & Nursing
ProQuest Pharma Collection
ProQuest Central China
Environmental Sciences and Pollution Management
ProQuest Central
ProQuest One Sustainability
ProQuest Health & Medical Research Collection
Health Research Premium Collection
Health and Medicine Complete (Alumni Edition)
Bacteriology Abstracts (Microbiology B)
Algology Mycology and Protozoology Abstracts (Microbiology C)
Health & Medical Research Collection
AIDS and Cancer Research Abstracts
ProQuest Central (New)
ProQuest Medical Library (Alumni)
ProQuest Public Health
Virology and AIDS Abstracts
ProQuest One Academic Eastern Edition
ProQuest Nursing & Allied Health Source
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
ProQuest Hospital Collection (Alumni)
Nursing & Allied Health Premium
ProQuest Health & Medical Complete
ProQuest Medical Library
ProQuest One Academic UKI Edition
ProQuest Nursing & Allied Health Source (Alumni)
ProQuest One Academic
ProQuest One Academic (New)
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList Pharma and Biotech Premium PRO
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: BENPR
  name: ProQuest Central Database Suite (ProQuest)
  url: https://www.proquest.com/central
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Public Health
EISSN 1474-4457
EndPage e123
ExternalDocumentID 39900094
10_1016_S1473_3099_25_00007_6
S1473309925000076
Genre Letter
Correspondence
GroupedDBID ---
--K
--M
-RU
..I
.1-
.FO
0R~
123
1B1
1P~
1~5
29L
4.4
457
4G.
53G
5VS
6PF
7-5
71M
7RV
7X7
88E
8AO
8C1
8C2
8FI
8FJ
AAAJQ
AAEDT
AAEDW
AAIKJ
AAKOC
AALRI
AAMRU
AAQFI
AAQQT
AAQXK
AARKO
AATTM
AAWTL
AAXKI
AAXUO
AAYWO
ABBQC
ABJNI
ABMAC
ABMZM
ABUWG
ABWVN
ACGFS
ACIEU
ACPRK
ACRLP
ACRPL
ACVFH
ADBBV
ADCNI
ADMUD
ADNMO
AEIPS
AEKER
AENEX
AEUPX
AEUYN
AEVXI
AFKRA
AFPUW
AFRAH
AFRHN
AFTJW
AFXIZ
AGCQF
AGEKW
AGHFR
AGQPQ
AHMBA
AIGII
AIIUN
AITUG
AJRQY
AJUYK
AKBMS
AKRWK
AKYEP
ALMA_UNASSIGNED_HOLDINGS
AMRAJ
ANZVX
APXCP
ASPBG
AVWKF
AXJTR
AZFZN
BENPR
BKEYQ
BKOJK
BNPGV
BPHCQ
BVXVI
CCPQU
CJTIS
CS3
DU5
EBS
EFJIC
EFKBS
EJD
EO8
EO9
EP2
EP3
EX3
F5P
FDB
FEDTE
FGOYB
FIRID
FNPLU
FYGXN
FYUFA
G-Q
GBLVA
HF~
HMCUK
HVGLF
HZ~
IHE
J1W
KOM
M1P
M41
MO0
N9A
NAPCQ
O-L
O9-
OD-
OO.
OZT
P-8
P-9
P2P
PHGZM
PHGZT
PJZUB
PPXIY
PQQKQ
PROAC
PSQYO
PUEGO
R2-
ROL
RPZ
SDG
SEL
SES
SPCBC
SSH
SSI
SSZ
T5K
TLN
UKHRP
UV1
WOW
XBR
Z5R
AACTN
AAYOK
AFCTW
ALIPV
RIG
AAYXX
AGRNS
CITATION
NPM
0TZ
3V.
7QL
7U9
7XB
8FK
C1K
H94
K9.
M7N
PKEHL
PQEST
PQUKI
PRINS
7X8
ID FETCH-LOGICAL-c395t-4acc5ee2eb336a734141d0344b754a5523f7992c929c15e0388283c355e4ca413
IEDL.DBID 7X7
ISSN 1473-3099
1474-4457
IngestDate Fri Jul 11 11:34:00 EDT 2025
Wed Aug 13 08:02:43 EDT 2025
Mon Jul 21 05:55:39 EDT 2025
Tue Jul 01 05:23:42 EDT 2025
Sat Mar 29 16:12:29 EDT 2025
Tue Aug 26 16:38:55 EDT 2025
IsPeerReviewed true
IsScholarly true
Issue 3
Language English
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c395t-4acc5ee2eb336a734141d0344b754a5523f7992c929c15e0388283c355e4ca413
Notes SourceType-Scholarly Journals-1
ObjectType-Correspondence-1
content type line 14
content type line 23
PMID 39900094
PQID 3171670209
PQPubID 44001
ParticipantIDs proquest_miscellaneous_3163222842
proquest_journals_3171670209
pubmed_primary_39900094
crossref_primary_10_1016_S1473_3099_25_00007_6
elsevier_sciencedirect_doi_10_1016_S1473_3099_25_00007_6
elsevier_clinicalkey_doi_10_1016_S1473_3099_25_00007_6
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate March 2025
2025-03-00
2025-Mar
20250301
PublicationDateYYYYMMDD 2025-03-01
PublicationDate_xml – month: 03
  year: 2025
  text: March 2025
PublicationDecade 2020
PublicationPlace United States
PublicationPlace_xml – name: United States
– name: London
PublicationTitle The Lancet infectious diseases
PublicationTitleAlternate Lancet Infect Dis
PublicationYear 2025
Publisher Elsevier Ltd
Elsevier Limited
Publisher_xml – name: Elsevier Ltd
– name: Elsevier Limited
References Li, Faraone, Hsu (bib2) 2024; 43
Zhang, Dopfer-Jablonka, Cossmann (bib1) 2024; 27
Panagiotakopoulos, Moulia, Godfrey (bib3) 2024; 73
Edara, Manning, Ellis (bib4) 2022; 3
Liu, Yu, Jian (bib5) 2024; 25
Zhang (10.1016/S1473-3099(25)00007-6_bib1) 2024; 27
Liu (10.1016/S1473-3099(25)00007-6_bib5) 2024; 25
Edara (10.1016/S1473-3099(25)00007-6_bib4) 2022; 3
Li (10.1016/S1473-3099(25)00007-6_bib2) 2024; 43
Panagiotakopoulos (10.1016/S1473-3099(25)00007-6_bib3) 2024; 73
References_xml – volume: 73
  start-page: 819
  year: 2024
  end-page: 824
  ident: bib3
  article-title: Use of COVID-19 vaccines for persons aged ≥6 months: recommendations of the advisory committee on immunization practices - United States, 2024–2025
  publication-title: MMWR Morb Mortal Wkly Rep
– volume: 43
  year: 2024
  ident: bib2
  article-title: Neutralization escape, infectivity, and membrane fusion of JN.1-derived SARS-CoV-2 SLip, FLiRT, and KP.2 variants
  publication-title: Cell Rep
– volume: 27
  year: 2024
  ident: bib1
  article-title: Rapid spread of the SARS-CoV-2 JN.1 lineage is associated with increased neutralization evasion
  publication-title: iScience
– volume: 3
  year: 2022
  ident: bib4
  article-title: mRNA-1273 and BNT162b2 mRNA vaccines have reduced neutralizing activity against the SARS-CoV-2 omicron variant
  publication-title: Cell Rep Med
– volume: 25
  start-page: e6
  year: 2024
  end-page: e7
  ident: bib5
  article-title: Enhanced immune evasion of SARS-CoV-2 variants KP.3.1.1 and XEC through N-terminal domain mutations
  publication-title: Lancet Infect Dis
– volume: 25
  start-page: e6
  year: 2024
  ident: 10.1016/S1473-3099(25)00007-6_bib5
  article-title: Enhanced immune evasion of SARS-CoV-2 variants KP.3.1.1 and XEC through N-terminal domain mutations
  publication-title: Lancet Infect Dis
  doi: 10.1016/S1473-3099(24)00738-2
– volume: 3
  year: 2022
  ident: 10.1016/S1473-3099(25)00007-6_bib4
  article-title: mRNA-1273 and BNT162b2 mRNA vaccines have reduced neutralizing activity against the SARS-CoV-2 omicron variant
  publication-title: Cell Rep Med
– volume: 43
  year: 2024
  ident: 10.1016/S1473-3099(25)00007-6_bib2
  article-title: Neutralization escape, infectivity, and membrane fusion of JN.1-derived SARS-CoV-2 SLip, FLiRT, and KP.2 variants
  publication-title: Cell Rep
  doi: 10.1016/j.celrep.2024.114520
– volume: 27
  year: 2024
  ident: 10.1016/S1473-3099(25)00007-6_bib1
  article-title: Rapid spread of the SARS-CoV-2 JN.1 lineage is associated with increased neutralization evasion
  publication-title: iScience
– volume: 73
  start-page: 819
  year: 2024
  ident: 10.1016/S1473-3099(25)00007-6_bib3
  article-title: Use of COVID-19 vaccines for persons aged ≥6 months: recommendations of the advisory committee on immunization practices - United States, 2024–2025
  publication-title: MMWR Morb Mortal Wkly Rep
  doi: 10.15585/mmwr.mm7337e2
SSID ssj0017104
Score 2.4720945
Snippet The limitations of this study include the small cohort size, age group, examination of a single timepoint, and unknown effect of previous SARS-CoV-2 exposure...
SourceID proquest
pubmed
crossref
elsevier
SourceType Aggregation Database
Index Database
Publisher
StartPage e122
SubjectTerms Antibodies
COVID-19
COVID-19 vaccines
FDA approval
Health sciences
Immune response
Immune response (cell-mediated)
Immunization
Infectious diseases
Mutation
Severe acute respiratory syndrome coronavirus 2
Title The KP.2-adapted COVID-19 vaccine improves neutralising activity against the XEC variant
URI https://www.clinicalkey.com/#!/content/1-s2.0-S1473309925000076
https://dx.doi.org/10.1016/S1473-3099(25)00007-6
https://www.ncbi.nlm.nih.gov/pubmed/39900094
https://www.proquest.com/docview/3171670209
https://www.proquest.com/docview/3163222842
Volume 25
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV1LbxQxDLZKKyEkhGh5LZQqSD3AIe1OJslsTgi2W7VFfQgomluUySSol9mF3eX3Y2cePRV6mcNMHGkcJ_5sxzbAvnCqjnrsuTOh5lIWkVcqVjyPaBEZj4hCU4Lz-YU-uZZnpSo7h9uyu1bZn4npoK7nnnzkhznVdSkQ3JiPi1-cukZRdLVrofEAtqh0GUl1UQ4GF1Kk9oGZLHKeIxS6zeA5_Da8fC_UhxTQ4_ou3XQX9kw66PgpPOnAI_vUrvY2bIRmBx6ed-HxHXjcOuFYm1v0DEoUAvbl6kBwV7sFYks2vfxxesQzw_44TzTsJjkVwpI1YZ2cHuQ7YJTtQE0lmPvpbhBAMoSJrJxNkQwFtlk9h-vj2ffpCe9aKXCfG7XiEidVIQg0nXPtClRdMqup2l9VKOkUWqOxMEZ4BEs-U4FKxCDu8AhGgvQOFd0L2GzmTXgFLMMBXoy9ikg6NoQ3qqhjLCaRyp6aERz0TLSLtmKGHa6SEdctcd0KZRPXrR6B7llt-3RQPMAsnun_I5wMhB1eaHHAfUh3-zW13aZd2lsRG8G74TNuN4qhuCbM1zRGU2xqIsUIXrayMPwlYr10U_P1vyd_A48ENRFOF9l2YXP1ex3eIrJZVXtJfPE5mWZ7sPV5dnH19S8HLu-E
linkProvider ProQuest
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3db9MwED-NIQESQjA-VhhgJJDgwVvj2E7zgBDqNrV0HUhsqG_GcWy0l7SjLYh_ir-RO-djTwNe9prkouR8vvv5PgFeCqvKoPuO29yXXMos8EKFgqcBT0S5Q0ShqcB5eqxHp_LDTM024HdbC0Npla1OjIq6nDvyke-l1NclQ3CTv1ucc5oaRdHVdoRGLRYT_-snHtmWb8f7uL6vhDg8OBmOeDNVgLs0VysurXPKe4GnyFTbDLW4TEpqfFdkSlqFB7OQ5blwiBtcojx1S0ET7NAue-ks6nx87zW4LlPcmlSZPuxSSvAL47jCRGYpTxF6XVQM7X3uLr4W6k0MIHJ9mS28DOtGm3d4F-40YJW9r6XrHmz4agtuTJtw_Bbcrp1-rK5lug8zFDo2-bQruC3tArEsG378Mt7nSc5-ID-Qhp1FJ4Zfssqvo5OFfBWMqitoiAWz3-wZAlaGsJTNDoZIhhukWj2A0yth8kPYrOaV3waW4ANO9J0KSNrPCd8UQYeQDQK1Wc17sNsy0SzqDh2mS10jrhviuhHKRK4b3QPdstq05aeoMA3akH8RDjrCBp_UuON_SHfaNTWNkliaC5HuwYvuNm5vitnYys_X9IymWNhAih48qmWh-0vEljEz9PHfX_4cbo5OpkfmaHw8eQK3BA0wjkl0O7C5-r72TxFVrYpnUZQZfL3qvfMHyrEnuQ
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9NAEB6VIlVICEF5BVpYJJDgsE289q7tA6pQ0qghtFSCoty26_Uu6sUJJAHx1_rrOrN-9FTg0qvjseLxPL6dJ8BrYWTp1cByk7uSJ0nqeSF9wWOPJ6LcIqJQ1OB8dKwOT5OPMznbgIu2F4bKKlubGAx1ObcUI-_HNNclRXCT931TFnEyGu8vfnDaIEWZ1nadRi0iU_fnNx7flu8nI_zWb4QYH3wdHvJmwwC3cS5XPDHWSucEnihjZVK06ElU0hC8IpWJkXhI82meC4sYwkbS0eQUdMcWfbRLrEH7j8-9BbfTOM1Ix7JhV16C_zasLoySNOYxwrCr7qH-l-7iWyHfhWQiV9f5xetwb_B_4_twrwGu7EMtaQ9gw1XbsHXUpOa34W4dAGR1X9NDmKEAsunJnuCmNAvEtWz4-dtkxKOc_UJ-IA07DwENt2SVW4eAC8UtGHVa0EILZr6bcwSvDCEqmx0MkQyVpVo9gtMbYfJj2KzmlXsKLMIbrBhY6ZF0kBPWKbzyPs08jVzNe7DXMlEv6mkduitjI65r4roWUgeua9UD1bJat62oaDw1-pN_EWYdYYNVagzyP6Q77TfVjcFY6ivx7sGr7mdUdcrfmMrN13SPorxYlogePKlloXtLxJmhSvTZ3x_-ErZQa_SnyfH0OdwRtMs41NPtwObq59rtIsBaFS-CJDM4u2nVuQQdyivv
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=The+KP.2-adapted+COVID-19+vaccine+improves+neutralising+activity+against+the+XEC+variant&rft.jtitle=The+Lancet+infectious+diseases&rft.au=Suthar%2C+Mehul+S&rft.au=Manning%2C+Kelly+E&rft.au=Ellis%2C+Madison+L&rft.au=Jain%2C+Shilpi&rft.date=2025-03-01&rft.eissn=1474-4457&rft.volume=25&rft.issue=3&rft.spage=e122&rft_id=info:doi/10.1016%2FS1473-3099%2825%2900007-6&rft_id=info%3Apmid%2F39900094&rft.externalDocID=39900094
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1473-3099&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1473-3099&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1473-3099&client=summon